Insights

Gathering insights about Wugen…

Similar companies to Wugen

Wugen Tech Stack

Wugen uses 8 technology products and services including Hotjar, Twitter Emoji (Twemoji), particles.js, and more. Explore Wugen's tech stack below.

Hotjar
Analytics
Twitter Emoji (Twemoji)
Font Scripts
particles.js
Javascript Graphics
Slick
Javascript Libraries
jQuery Migrate
Javascript Libraries
Open Graph
Miscellaneous
Microsoft Teams
Team Collaboration
Animate.css
UI Frameworks

Media & News

Wugen Inc launches RMAT and PRIME Designations for WU-CART-007.
Wugen announces RMAT and PRIME Designations for WU-CART-007 to accelerate regulatory reviews and plans to Present positive Phase 2 study Findings at European Hematology Association (EHA) 2024 in June.
May 20, 2024 | finance.yahoo.com
Wugen Inc hired Mark Alles as Chair of the Board of Directors on May 10th '23.
Wugen appoints industry leader Mark Alles as Chair of the Board of Directors.
May 09, 2023 | wugen.com
Biobuzz partners with Wugen Inc.
“Biobuzz is delighted to partner with Wugen to help make these life-saving cancer treatments less challenging to produce and more accessible to patients in need.”
Jun 22, 2022 | biobuzz.io
OXGENE is a trading name of Oxford Genetics LTD. partners with Wugen Inc.
"Oxgene is delighted to partner with Wugen to help make these life-saving cancer treatments less challenging to produce and more accessible to patients in need."
Jun 15, 2022 | oxgene.com
WuXi AppTec Group partners with Wugen Inc.
“WuXi AppTec is delighted to partner with Wugen to help make these life-saving cancer treatments less challenging to produce and more accessible to patients in need.”
Jun 15, 2022 | www.wuxiapptec.com
Advancedtherapies partners with Wugen Inc.
“Advancedtherapies is delighted to partner with Wugen to help make these life-saving cancer treatments less challenging to produce and more accessible to patients in need.”
Jun 15, 2022 | advancedtherapies.com
Tybourne Capital invested into Wugen Inc $172M on Jul 15th '21.
Wugen, Inc., a clinical stage biotechnology company developing a pipeline of off-the-shelf cell therapies, today announced the completion of an oversubscribed $172 million Series B financing led by Abingworth and Tybourne Capital Management, and joined by new investors Fidelity Management & Research Company, Intermediate Capital Group (ICG), Sands Capital, Aisling Capital Management, Alexandria Venture Investments, Velosity Capital and Falcon Edge Capital.
Jul 13, 2021 | www.businesswire.com

Wugen's Email Address Formats

Wugen uses at least 1 format(s):

Wugen Email Formats	Example	Percentage
FLast@wugen.com	JDoe@wugen.com	97%
Last.F@wugen.com	Doe.J@wugen.com	2%
FirLast@wugen.com	JohDoe@wugen.com	1%

Frequently Asked Questions

Where is Wugen's headquarters located?

Wugen's main headquarters is located at 4260 Forest Park Ave Suite 100 St. Louis, Missouri 63108 US. The company has employees across 2 continents, including North AmericaEurope.

What is Wugen's official website and social media links?

Wugen's official website is wugen.com and has social profiles on LinkedIn.

How much revenue does Wugen generate?

As of September 2024, Wugen's annual revenue reached $15M.

What is Wugen's SIC code NAICS code?

Wugen's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Wugen have currently?

As of September 2024, Wugen has approximately 69 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: K. S.Chief Operating Officer, Executive Vice President Of Research & Development: A. K.Chief Financial Officer: K. V.. Explore Wugen's employee directory with LeadIQ.

What industry does Wugen belong to?

Wugen operates in the Biotechnology Research industry.

What technology does Wugen use?

Wugen's tech stack includes HotjarTwitter Emoji (Twemoji)particles.jsSlickjQuery MigrateOpen GraphMicrosoft TeamsAnimate.css.

What is Wugen's email format?

Wugen's email format typically follows the pattern of . Find more Wugen email formats with LeadIQ.

How much funding has Wugen raised to date?

As of September 2024, Wugen has raised $172M in funding. The last funding round occurred on Jul 15, 2021 for $172M.

When was Wugen founded?

Wugen was founded in 2018.

Wugen

Biotechnology ResearchMissouri, United States51-200 Employees

Wugen is a clinical-stage biotechnology company developing the next generation of off-the-shelf memory natural killer (NK) and CAR-T cell therapies for cancer. Wugen is leveraging its proprietary Moneta platform and deep genomic engineering expertise to pioneer a new class of memory NK cell therapies to treat hematological and solid tumor malignancies.

Wugen is based out of St. Louis, Missouri and San Diego, California.

Company Overview

Headquarters: 4260 Forest Park Ave Suite 100 St. Louis, Missouri 63108 US
Website: wugen.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2018
Employees: 51-200

Media & News

Funding & Financials

$172M
Wugen has raised a total of $172M of funding over 2 rounds. Their latest funding round was raised on Jul 15, 2021 in the amount of $172M.
$10M$50M
Wugen's revenue is in the range of $10M$50M

Funding & Financials

$172M
Wugen has raised a total of $172M of funding over 2 rounds. Their latest funding round was raised on Jul 15, 2021 in the amount of $172M.
$10M$50M
Wugen's revenue is in the range of $10M$50M

Company Leadership

K. S.
Chief Executive Officer
✕
Access Insights for Wugen and Millions of Other Companies
Sign up for full access to Wugen information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Wugen and Millions of Other Companies
Sign up for full access to Wugen information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. K.
Chief Operating Officer, Executive Vice President Of Research & Development
✕
Access Insights for Wugen and Millions of Other Companies
Sign up for full access to Wugen information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Wugen and Millions of Other Companies
Sign up for full access to Wugen information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. V.
Chief Financial Officer
✕
Access Insights for Wugen and Millions of Other Companies
Sign up for full access to Wugen information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Wugen and Millions of Other Companies
Sign up for full access to Wugen information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. T. T.
Chief Medical Officer
✕
Access Insights for Wugen and Millions of Other Companies
Sign up for full access to Wugen information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Wugen and Millions of Other Companies
Sign up for full access to Wugen information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. C.
Chief Scientific Officer
✕
Access Insights for Wugen and Millions of Other Companies
Sign up for full access to Wugen information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Wugen and Millions of Other Companies
Sign up for full access to Wugen information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

J. D.
Chief Medical Officer
✕
Access Insights for Wugen and Millions of Other Companies
Sign up for full access to Wugen information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Wugen and Millions of Other Companies
Sign up for full access to Wugen information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. S.
Chief Executive Officer
✕
Access Insights for Wugen and Millions of Other Companies
Sign up for full access to Wugen information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Wugen and Millions of Other Companies
Sign up for full access to Wugen information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
T. F.
Co-Founder
✕
Access Insights for Wugen and Millions of Other Companies
Sign up for full access to Wugen information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Wugen and Millions of Other Companies
Sign up for full access to Wugen information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. D.
Vice President, Quality
✕
Access Insights for Wugen and Millions of Other Companies
Sign up for full access to Wugen information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Wugen and Millions of Other Companies
Sign up for full access to Wugen information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. L.
Vice President, Finance And Business Operations
✕
Access Insights for Wugen and Millions of Other Companies
Sign up for full access to Wugen information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Wugen and Millions of Other Companies
Sign up for full access to Wugen information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Wugen

Immunocore

OmniSeq

Agenus

CytomX Therapeutics

GammaDelta Therapeutics

Carisma Therapeutics

TScan Therapeutics

Bright Peak Therapeutics

Wugen Tech Stack

Media & News

Wugen Inc launches RMAT and PRIME Designations for WU-CART-007.

Wugen Inc hired Mark Alles as Chair of the Board of Directors on May 10th '23.

Biobuzz partners with Wugen Inc.

OXGENE is a trading name of Oxford Genetics LTD. partners with Wugen Inc.

WuXi AppTec Group partners with Wugen Inc.

Advancedtherapies partners with Wugen Inc.

Tybourne Capital invested into Wugen Inc $172M on Jul 15th '21.

Wugen's Email Address Formats

Frequently Asked Questions

Where is Wugen's headquarters located?

What is Wugen's official website and social media links?

How much revenue does Wugen generate?

What is Wugen's SIC code NAICS code?

How many employees does Wugen have currently?

What industry does Wugen belong to?

What technology does Wugen use?

What is Wugen's email format?

How much funding has Wugen raised to date?

When was Wugen founded?

Wugen

Company Overview

Media & News

Wugen Inc launches RMAT and PRIME Designations for WU-CART-007.

Wugen Inc hired Mark Alles as Chair of the Board of Directors on May 10th '23.

Biobuzz partners with Wugen Inc.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?